Ruth Ganss
Ruth Ganss
Head Vascular Biology and Stromal Targeting, Harry Perkins Institute of Medical Research
Verified email at
Cited by
Cited by
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
R Du, KV Lu, C Petritsch, P Liu, R Ganss, E Passegué, H Song, ...
Cancer cell 13 (3), 206-220, 2008
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
J Hamzah, M Jugold, F Kiessling, P Rigby, M Manzur, HH Marti, T Rabie, ...
Nature 453 (7193), 410-414, 2008
Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors
E Hummler, TJ Cole, JA Blendy, R Ganss, A Aguzzi, W Schmid, ...
Proceedings of the National Academy of Sciences 91 (12), 5647-5651, 1994
Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication
R Ganss, E Ryschich, E Klar, B Arnold, GJ Hämmerling
Cancer research 62 (5), 1462-1470, 2002
Lymphatic endothelium‐specific hyaluronan receptor LYVE‐1 is expressed by stabilin‐1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in …
K Schledzewski, M Falkowski, G Moldenhauer, P Metharom, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006
Chemokines direct endothelial progenitors into tumor neovessels
H Spring, T Schüler, B Arnold, GJ Hämmerling, R Ganss
Proceedings of the National Academy of Sciences 102 (50), 18111-18116, 2005
NK-and CD8+ T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides
Y Kawarada, R Ganss, N Garbi, T Sacher, B Arnold, GJ Hämmerling
The Journal of Immunology 167 (9), 5247-5253, 2001
Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization
M Berger, G Bergers, B Arnold, GJ Hämmerling, R Ganss
Blood 105 (3), 1094-1101, 2005
Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes
R Ganss, D Hanahan
Cancer research 58 (20), 4673-4681, 1998
CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction
N Garbi, B Arnold, S Gordon, GJ Hämmerling, R Ganss
The Journal of Immunology 172 (10), 5861-5869, 2004
A cell‐specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number‐related expression in transgenic mice.
R Ganss, L Montoliu, AP Monaghan, G Schütz
The EMBO journal 13 (13), 3083-3093, 1994
Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy
A Johansson, J Hamzah, CJ Payne, R Ganss
Proceedings of the National Academy of Sciences 109 (20), 7841-7846, 2012
Transformation of the microvascular system during multistage tumorigenesis
E Ryschich, J Schmidt, GJ Hämmerling, E Klar, R Ganss
International journal of cancer 97 (6), 719-725, 2002
Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM
R Du, C Petritsch, K Lu, P Liu, A Haller, R Ganss, H Song, S Vandenberg, ...
Neuro-oncology 10 (3), 254-264, 2008
The mouse tyrosinase gene. Promoter modulation by positive and negative regulatory elements.
R Ganss, G Schütz, F Beermann
Journal of Biological Chemistry 269 (47), 29808-29816, 1994
Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma
E Ryschich, P Lizdenis, C Ittrich, A Benner, S Stahl, A Hamann, J Schmidt, ...
Cancer research 66 (1), 198-211, 2006
Secreted frizzled-related protein 4: an angiogenesis inhibitor
A Muley, S Majumder, GK Kolluru, S Parkinson, H Viola, L Hool, F Arfuso, ...
The American journal of pathology 176 (3), 1505-1516, 2010
Mini‐review: overcoming tumor‐intrinsic resistance to immune effector function
R Ganss, B Arnold, GJ Hämmerling
European journal of immunology 34 (10), 2635-2641, 2004
De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors
A Johansson-Percival, B He, ZJ Li, A Kjellén, K Russell, J Li, I Larma, ...
Nature immunology 18 (11), 1207, 2017
The cyclic adenosine 3', 5'-monophosphate-and the glucocorticoid-dependent enhancers are targets for insulin repression of tyrosine aminotransferase gene transcription.
R Ganss, F Weih, G Schütz
Molecular Endocrinology 8 (7), 895-903, 1994
The system can't perform the operation now. Try again later.
Articles 1–20